Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
SAN FRANCISCO, March 20 /PRNewswire-FirstCall/ -- Medivation, Inc. (NASDAQ:MDVN) today announced that its common stock will begin trading on The Nasdaq Global Market under the symbol MDVN at the...
SAN FRANCISCO, March 19 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that six-month results from its randomized, double-blinded, placebo-controlled Phase 2 efficacy...
Dutton Associates continues its coverage of Medivation Inc. (AMEX:MDV) reiterating a Strong Speculative Buy rating and a $27.00 price target. The 12-page report by Dutton senior...
SAN FRANCISCO, March 8 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that The Nasdaq Listing Qualifications Department has approved the Company's application to list its...
SAN FRANCISCO, March 5 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that David Hung, M.D., president and chief executive officer, will present at Cowen and Company's...
- Data Presented in Oral and Poster Presentations at ASCO's Prostate Cancer Symposium - SAN FRANCISCO, Feb. 26 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that results...
SAN FRANCISCO, Feb. 16 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that preclinical efficacy data on MDV3100, a novel small molecule the Company is developing to treat...
SAN FRANCISCO, Feb. 5 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that David Hung, M.D., president and chief executive officer, will present at the 9th Annual BIO CEO...
SAN FRANCISCO, Jan. 30 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that results of its Phase 2 efficacy study of Dimebon(TM) in Alzheimer's disease will be presented at...
SAN FRANCISCO, Jan. 17 /PRNewswire/ -- Medivation, Inc. (AMEX:MDV) today announced that it has appointed Lisa Taylor as vice president of commercial development. Ms. Taylor is responsible for...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Symbole | Prix | Vol. |
|---|---|---|
| MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 1,29 (26,47%) | 535,06M |
| OPTTOcean Power Technologies Inc | US$ 0,28905 (61,48%) | 255,93M |
| FOXOFOXO Technologies Inc | US$ 0,523199 (35,58%) | 133,9M |
| KULRKULR Technology Group Inc | US$ 0,77 (-2,53%) | 115,5M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 28,13 (-4,09%) | 73,2M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
